CA
IDYA icon

Continuum Advisory’s IDEAYA Biosciences IDYA Stock Holding History

Continuum Advisory’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.04K Buy
+162
New +$4.96K ﹤0.01% 1414
2025
Q2 		– Sell
-69
Closed -$1.13K – 942
2025
Q1 		$1.13K Buy
69
+1
+1% +$21 ﹤0.01% 1488
2024
Q4 		$1.75K Hold
68
– – ﹤0.01% 1459
2024
Q3 		$2K Buy
68
+32
+89% +$1.21K ﹤0.01% 1428
2024
Q2 		$1.26K Buy
36
+8
+29% +$317 ﹤0.01% 1423
2024
Q1 		$1.14K Buy
+28
New +$1.2K ﹤0.01% 1443

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Continuum Advisory's IDYA Position: Q2 2026 in Review

Continuum Advisory opened a new position in IDEAYA Biosciences (IDYA) in Q2 2026: 162 shares worth $6.04K. The stake represents ﹤0.01% of the portfolio and ranks #1414 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in IDYA as recently as Q1 2025.

Continuum Advisory first reported a position in IDYA in Q1 2024 and has held it in 6 quarters since. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Continuum Advisory held 162 shares of IDEAYA Biosciences worth $6.04K as of Q2 2026.
  • IDEAYA Biosciences was a new Continuum Advisory position in Q2 2026.
  • IDEAYA Biosciences made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #1414 holding.
  • Continuum Advisory first reported a position in IDEAYA Biosciences in Q1 2024 and has held it in 6 quarters since.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.